Philipp Höhn

6PUBLICATIONS
12CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersMajor global burdens of diseaseTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 07, 2026
Bile does not increase the aggressiveness of pancreatic fluid towards fibrin-based sealants in a short-term ex-vivo setting.

|Mar 07, 2023
Applicability of the surgical risk calculator by the American College of Surgeons in the setting of German patients undergoing complete pancreatectomy: multicentre study using data from the StuDoQ|Pancreas registry.

Philipp Höhn, Fabian Runde, Andreas Minh Luu

|Oct 14, 2022
Risk Factor Identification for Delayed Gastric Emptying after Distal Pancreatectomy-An Evaluation of 1688 Patients Based on the German StuDoQ|Pancreas Registry.

Tim Fahlbusch, Philipp Höhn, Carsten Klinger

|Jul 09, 2022
Substance GP-2250 as a New Therapeutic Agent for Malignant Peritoneal Mesothelioma-A 3-D In Vitro Study.

Claudia Baron, Marie Buchholz, Britta Majchrzak-Stiller

|Jan 11, 2019
Outcome Determining Factors of Intraductal Papillary Neoplasm of the Biliary Tract (IPNB)-a Single Center Survey and Analysis of Current Literature.

Philipp Höhn, Chris Braumann, Johanna Munding

|Jul 04, 2017
Dose-dependent role of novel agents emodin and BTB14431 in colonic cancer treatment in rats.

Chris Braumann, Gerold Koplin, Caroline Geier

Pageof 1

Frequent Collaborators

2 joint publications

Britta Majchrzak-Stiller

2 joint publications

Johanna Strotmann

2 joint publications

Waldemar Uhl

1 joint publications

Gerold Koplin